Resources from the same session
LBA21 - Neoadjuvant mFOLFIRINOX and preoperative chemoradiation (CRT) versus preoperative CRT in patients with T3-4 rectal cancer: Surgical and quality of life results of PRODIGE 23 phase III trial
Presenter: Christophe Borg
Session: Mini Oral - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
400MO - Curative chemoradiation for low rectal cancer: Early clinical outcomes from a multicentre phase II trial
Presenter: Lars Henrik Jensen
Session: Mini Oral - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
401MO - OS and long-term DFS with 3- vs. 6-month adjuvant oxaliplatin and fluoropyrimidine-based therapy for stage III colon cancer patients: A randomized phase III ACHIEVE trial
Presenter: Takayuki Yoshino
Session: Mini Oral - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
402MO - Final results of the CARACAS study: Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic squamous cell anal carcinoma progressed to at least one line of treatment
Presenter: Sara Lonardi
Session: Mini Oral - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
403MO - Atezolizumab in combination with bevacizumab for patients with unresectable/metastatic anal cancer
Presenter: Van Morris
Session: Mini Oral - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
404MO - Clinical relevance of MIR27A rs895819 polymorphism and its interaction with DPYD variants for predicting grade 4-5 fluoropyrimidine (FP) toxicity (tox) in the FUSAFE individual patient data meta-analysis (IPD-MA)
Presenter: Marie-Christine Etienne-Grimaldi
Session: Mini Oral - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
405MO - Personalized circulating tumour DNA assay for the detection of minimal residual disease in CRC patients after resection of metastases
Presenter: Fotios Loupakis
Session: Mini Oral - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
406MO - Sequencing paired tumor DNA and white blood cells (WBCs) increases sensitivity to track plasma circulating tumor DNA (ctDNA) for detecting minimal residual disease (MRD) in localized colon cancer (CC)
Presenter: Noelia Tarazona
Session: Mini Oral - Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
Open & welcome
Presenter: Michel Ducreux
Session: Mini Oral - Gastrointestinal tumours, colorectal
Resources:
Slides
Webcast
Invited Discussant 402MO and 403MO
Presenter: Michel Ducreux
Session: Mini Oral - Gastrointestinal tumours, colorectal
Resources:
Slides
Webcast